NCT01435629View on ClinicalTrials.gov

A Survey Collecting Data on Adult Height in Patients With Achondroplasia Treated With Somatropin

CompletedOBSERVATIONAL

Enrollment

81

Participants

Timeline

Start Date

November 22, 2012

Primary Completion Date

December 4, 2015

Study Completion Date

December 4, 2015

Conditions

Genetic DisorderAchondroplasia

Interventions

DRUG

somatropin

Dosage and administration to be prescribed by the physician as a result of a normal clinical practice.

Trial Locations (1)

1000005

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY